Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Physical Chemistry Chemical Physics : PCCP|February 5, 2025
Pressure-dependent optoelectronic properties of antiperovskite derivatives X<sub>3</sub>AsCl<sub>3</sub> (X = Mg, Ca, Sr, Ba): a first-principles studyTao Hu, Changhe Wu, Mingjun Li, et al.
International Journal of Oncology|March 4, 2016
miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2Kaiyao Hua, Jiali Jin, Junyong Zhao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 16, 2021
RNF216 regulates meiosis and PKA stability in the testesDengfeng Li, Fangfang Li, Lanlan Meng, et al.
Oncotarget|November 22, 2017
The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cellsDengfeng Li, Hong Wang, Hongming Song, et al.
Cancer Letters|March 28, 2018
Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasisDengfeng Li, Hong Wang, Ye Ding, et al.
Oncology Reports|October 2, 2018
MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase 1 in breast cancer cellsDan Xie, Hongming Song, Tianqi Wu, et al.
Journal of Medicinal Chemistry|March 13, 2018
Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent WarheadsYe Ding, Dengfeng Li, Chunyong Ding, et al.
ACS Applied Materials & Interfaces|May 23, 2020
<i>In Situ</i> Formation of Nanotheranostics to Overcome the Blood-Brain Barrier and Enhance Treatment of Orthotopic GliomaHaiyan Gao, Chengchao Chu, Yi Cheng, et al.
The Journal of Biological Chemistry|June 9, 2026
FTO Promotes Cancer Progression by Regulating VGLL4 m6A Levels to Activate STAT3 Signaling in Triple-Negative Breast CancerHongming Song, Jihong Lu, Yining Zhang, et al.
Diabetes|February 23, 2024
Multiomics Analyses Identify AKR1A1 as a Biomarker for Diabetic Kidney DiseaseDengFeng Li, Fang-Chi Hsu, Nicholette D Palmer, et al.
Pageof 18